BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29263314)

  • 1. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
    Ye F; Jin P; Cai X; Cai P; Cai H
    Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
    Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
    Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
    Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
    Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
    Jögi A; Brennan DJ; Rydén L; Magnusson K; Fernö M; Stål O; Borgquist S; Uhlen M; Landberg G; Påhlman S; Pontén F; Jirström K
    Mod Pathol; 2009 Dec; 22(12):1564-74. PubMed ID: 19734850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
    Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
    Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
    PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
    Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
    Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
    J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
    PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
    Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
    Biomark Res; 2014; 2():11. PubMed ID: 24963396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.
    Yang Q; Ye Z; Zhang Q; Zhao Z; Yuan H
    Tumour Biol; 2016 Jan; 37(1):1189-95. PubMed ID: 26282002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
    Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
    Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.
    Salomonsson A; Micke P; Mattsson JSM; La Fleur L; Isaksson J; Jönsson M; Nodin B; Botling J; Uhlén M; Jirström K; Staaf J; Planck M; Brunnström H
    Cancer Med; 2020 Aug; 9(15):5609-5619. PubMed ID: 32491279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of noggin protein expression in patients with resected gastric cancer.
    Chun SH; Kim EY; Yoon JS; Won HS; Yim K; Hwang HW; Hong SA; Lee M; Lee SL; Kim SS; Sun S; Ko YH
    BMC Cancer; 2021 May; 21(1):558. PubMed ID: 34001012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.